U.S. authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use
Shots for health workers and nursing home residents are expected to begin in the coming days after the U.S. Food and Drug Administration authorized an emergency rollout of what promises to be a strongly protective vaccine from Pfizer Inc. and its German partner BioNTech.